FDA sets up monitoring program for Accutane

All patients, doctors and pharmacists involved with the prescription acne drug Accutane and three generic versions are to be placed on a national registry by the FDA as a way of trying to prevent women from becoming pregnant while taking the drug. The intent is to make sure women are monitored if they become pregnant because Roche's drug has been found to cause birth defects related to the face and central nervous system.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN